The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
Authors:
- Linda E. CarlsonLinda E. Carlson
- Harriet RichardsonHRHarriet Richardson
- Ron ShoreRSRon Shore
- Christopher P. AlbertynCAChristopher P. Albertyn
- Lynda G. BalneavesLynda G. Balneaves
- Alan BatesABAlan Bates
- Margot BurnellMBMargot Burnell
- Harvey Max ChochinovHCHarvey Max Chochinov
- David ClementsDCDavid Clements
- Julie DeleemansJulie Deleemans
- Hilary HorlockHHHilary Horlock
- Jean MathewsJMJean Mathews
Open Access
- 22 December 2025
- journal article
- review article
- Published by MDPI AG in Current Oncology
- Vol. 33 (1) , 7
Abstract
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary research and practice network; (2) to set research priorities through structured stakeholder engagement; (3) to develop and provide PAT training and education for clinicians, researchers, and patients; (4) to pilot test the feasibility of intervention and assessment procedures; (5) to conduct a multi-center, randomized controlled trial of PAT for people with advanced cancer; and (6) to inform and influence healthcare policy on PAT in Canada. We discuss the background and need for PAT in cancer, describe challenges currently limiting its use, and outline CAN-PACT’s strategy for building capacity, generating Canadian evidence, and preparing the oncology healthcare environment for potential implementation. This manuscript presents a summary overview of CAN-PACT as a multi-objective research program; detailed protocols for each discrete study component will be published separately as the research program progresses. Through environmental scans, national engagement, targeted training, rigorous research, and ongoing collaboration with policymakers, CAN-PACT aims to enable equitable access to safe, evidence-based PAT for people with advanced cancer in Canada’s publicly funded cancer centers.Keywords
Funding Information
- Canadian Cancer Society (708628)
- Canadian Institutes of Health Research (PJK—198294)
This publication has 44 references indexed in Scilit:
- Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trialsJournal of Affective Disorders, 2025
- Ethnoracial inclusion in clinical trials of psychedelics: a systematic revieweClinicalMedicine, 2024
- Distinguishing and treating demoralization syndrome in cancer: A reviewGeneral Hospital Psychiatry, 2023
- HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management, 2023
- Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression DisorderJAMA Oncology, 2023
- A systematic literature review of clinical trials and therapeutic applications of ibogaineJournal of Substance Abuse Treatment, 2022
- PsychedelicsCurrent Biology, 2022
- The psychosocial cost burden of cancer: A systematic literature reviewPsycho-Oncology, 2020
- Distinguishing Between Spiritual Distress, General Distress, Spiritual Well-Being, and Spiritual Pain Among Cancer Patients During Oncology TreatmentJournal of Pain and Symptom Management, 2017
- A Systematic Review of the Demoralization Syndrome in Individuals With Progressive Disease and Cancer: A Decade of ResearchJournal of Pain and Symptom Management, 2015